Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total
Beginning Balance at Dec. 31, 2020	$ 8	$ 424,823	$ (317,506)		$ 107,325
Beginning Balance (in shares) at Dec. 31, 2020	81,669,151
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(65,101)		(65,101)
Stock-based compensation		4,462			4,462
Stock-based compensation - earnout		12,373			12,373
Issuance of common stock for acquisitions		1,169			1,169
Issuance of common stock for acquisitions (in shares)	90,000
Reclassification of earnout liability upon vesting		25,815			25,815
Vesting of restricted stock awards (in shares)	2,078,102
Exercise of stock warrants	$ 1	93,007			93,008
Exercise of stock warrants (in shares)	8,087,623
Exercise of stock options		355			355
Exercise of stock options (in shares)	593,106
Income tax withholdings		(16,997)			(16,997)
Income tax withholdings (in shares)	(1,062,250)
Transaction costs		(402)			(402)
Ending Balance at Mar. 31, 2021	$ 9	544,605	(382,607)		162,007
Ending Balance (in shares) at Mar. 31, 2021	91,455,732
Beginning Balance at Dec. 31, 2020	$ 8	424,823	(317,506)		107,325
Beginning Balance (in shares) at Dec. 31, 2020	81,669,151
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss					(86,497)
Ending Balance at Sep. 30, 2021	$ 10	596,156	(404,003)	$ 113	192,276
Ending Balance (in shares) at Sep. 30, 2021	97,332,998
Beginning Balance at Mar. 31, 2021	$ 9	544,605	(382,607)		162,007
Beginning Balance (in shares) at Mar. 31, 2021	91,455,732
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(16,297)		(16,297)
Other comprehensive loss				267	267
Stock-based compensation		2,466			2,466
Stock-based compensation - earnout		4,176			4,176
Issuance of common stock for acquisitions		28,372			28,372
Issuance of common stock for acquisitions (in shares)	1,292,441
Reclassification of private warrant liability upon exercise		16,843			16,843
Vesting of restricted stock awards (in shares)	33,182
Exercise of stock warrants	$ 1	33,761			33,762
Exercise of stock warrants (in shares)	2,862,312
Exercise of stock options		2,227			2,227
Exercise of stock options (in shares)	946,392
Income tax withholdings		(5,194)			(5,194)
Income tax withholdings (in shares)	(296,643)
Transaction costs		140			140
Ending Balance at Jun. 30, 2021	$ 10	627,396	(398,904)	267	228,769
Ending Balance (in shares) at Jun. 30, 2021	96,293,416
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(5,099)		(5,099)
Other comprehensive loss				(154)	(154)
Stock-based compensation		1,641			1,641
Stock-based compensation - earnout		4,243			4,243
Issuance of common stock for acquisitions		1,937			1,937
Issuance of common stock for acquisitions (in shares)	102,636
Reclassification of private warrant liability upon exercise		14,505			14,505
Vesting of restricted stock awards (in shares)	271,432
Exercise of stock warrants (in shares)	557,816
Exercise of stock options		934			934
Exercise of stock options (in shares)	339,150
Income tax withholdings		(1,587)			(1,587)
Income tax withholdings (in shares)	(231,452)
Capped call transactions		(52,913)			(52,913)
Ending Balance at Sep. 30, 2021	$ 10	596,156	(404,003)	113	192,276
Ending Balance (in shares) at Sep. 30, 2021	97,332,998
Beginning Balance at Dec. 31, 2021	$ 10	641,406	(424,112)	(259)	217,045
Beginning Balance (in shares) at Dec. 31, 2021	97,961,597
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(5,796)		(5,796)
Other comprehensive loss				(2,515)	(2,515)
Stock-based compensation		5,854			5,854
Contingent consideration for acquisitions		530			530
Vesting of restricted stock awards (in shares)	245,855
Exercise of stock options		473			473
Exercise of stock options (in shares)	185,685
Income tax withholdings		(712)			(712)
Income tax withholdings (in shares)	(95,951)
Ending Balance at Mar. 31, 2022	$ 10	647,551	(429,908)	(2,774)	214,879
Ending Balance (in shares) at Mar. 31, 2022	98,297,186
Beginning Balance at Dec. 31, 2021	$ 10	641,406	(424,112)	(259)	217,045
Beginning Balance (in shares) at Dec. 31, 2021	97,961,597
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss					(118,564)
Ending Balance at Sep. 30, 2022	$ 10	664,362	(542,676)	(6,571)	115,125
Ending Balance (in shares) at Sep. 30, 2022	100,410,325
Beginning Balance at Mar. 31, 2022	$ 10	647,551	(429,908)	(2,774)	214,879
Beginning Balance (in shares) at Mar. 31, 2022	98,297,186
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(26,377)		(26,377)
Other comprehensive loss				(1,785)	(1,785)
Stock-based compensation		9,702			9,702
Issuance of common stock for acquisitions		3,552			3,552
Issuance of common stock for acquisitions (in shares)	628,660
Vesting of restricted stock awards (in shares)	563,406
Exercise of stock options		219			219
Exercise of stock options (in shares)	88,772
Income tax withholdings		(1,210)			(1,210)
Income tax withholdings (in shares)	(137,496)
Ending Balance at Jun. 30, 2022	$ 10	659,814	(456,285)	(4,559)	198,980
Ending Balance (in shares) at Jun. 30, 2022	99,440,528
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(86,391)		(86,391)
Other comprehensive loss				(2,012)	(2,012)
Stock-based compensation		5,089			5,089
Vesting of restricted stock awards (in shares)	1,062,323
Exercise of stock options		416			416
Exercise of stock options (in shares)	197,758
Income tax withholdings		(957)			(957)
Income tax withholdings (in shares)	(290,284)
Ending Balance at Sep. 30, 2022	$ 10	$ 664,362	$ (542,676)	$ (6,571)	$ 115,125
Ending Balance (in shares) at Sep. 30, 2022	100,410,325